Medicamen Biotech Limited has informed the Exchange regarding 'Corrigendum to the Outcome of the Meeting of Board of Directors of Medicamen Biotech Limited ( the Company ) in accordance with Regulation 30 of the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015'.